Centric Wealth Management’s Gilead Sciences GILD Stock Holding History

Centric Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.52M	Hold	26,506	–	–	0.55%	50
2026 Q1	$3.52M	Sell	26,506 -579	-2%	-$81.1K	0.7%	45
2025 Q4	$3.87M	Buy	27,085 +1,384	+5%	+$168K	0.82%	39
2025 Q3	$3.08M	Buy	25,701 +1,678	+7%	+$191K	0.69%	53
2025 Q2	$2.87M	Buy	24,023 +2,736	+13%	+$291K	0.68%	52
2025 Q1	$2.39M	Buy	21,287 +5,396	+34%	+$557K	0.63%	57
2024 Q4	$1.47M	Buy	+15,891	New	+$1.43M	0.4%	71
2020 Q4	–	Sell	-3,253	Closed	-$200K	–	218
2020 Q3	$200K	Sell	3,253 -12,023	-79%	-$834K	0.15%	110
2020 Q2	$1.18M	Buy	15,276 +12,023	+370%	+$921K	0.62%	44
2020 Q1	$200K	Sell	3,253 -7,555	-70%	-$522K	0.15%	110
2019 Q4	$702K	Buy	10,808 +7,555	+232%	+$492K	0.56%	44
2019 Q3	$200K	Buy	3,253 +50	+2%	+$3.27K	0.15%	110
2019 Q2	$216K	Buy	+3,203	New	+$211K	0.19%	93

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centric Wealth Management's GILD Position: Q2 2026 in Review

Centric Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 26,506 shares worth $3.52M. The position accounts for 0.55% of the portfolio, ranked #50.

Centric Wealth Management first reported a position in GILD in Q2 2019 and has held it in 13 quarters since. The position peaked at $3.87M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Centric Wealth Management held 26,506 shares of Gilead Sciences worth $3.52M as of Q2 2026.
Centric Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.55% of Centric Wealth Management's portfolio in Q2 2026, its #50 holding.
Centric Wealth Management first reported a position in Gilead Sciences in Q2 2019 and has held it in 13 quarters since.
Centric Wealth Management's Gilead Sciences position peaked at $3.87M in Q4 2025.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Centric Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.